Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
Status:
Not yet recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
This study will test the effectiveness of naltrexone/bupropion medication as a maintenance
therapy for the treatment of loss-of-control eating and weight loss following bariatric
surgery. This is a controlled test of whether, amongst responders to acute treatments,
naltrexone/bupropion medication results in superior maintenance and longer-term outcomes
compared with placebo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)